Drugs / MeningitecTM
last change Nov 2012 re-read 2 minutes ago

MeningitecTM

Developed for
meningococcal infection
Investigated by
GlaxoSmithKline

Trials 1 · a red edge is where a trial was stopped

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00891176 May 2009 → Nov 2012 haemophilus infectious disease, meningococcal infection GlaxoSmithKline Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MeningitecTM ClinicalTrials.gov intervention name — accepted as the source's own label NCT00891176